Literature DB >> 9973487

Functional characterization of the somatic hypermutation process leading to antibody D1.3, a high affinity antibody directed against lysozyme.

P England1, R Nageotte, M Renard, A L Page, H Bedouelle.   

Abstract

The impact of somatic hypermutation on the affinity of Abs directed against protein Ags remains poorly understood. We chose as a model the secondary response Ab D1.3 directed against hen egg lysozyme. During the maturation process leading to this Ab, five replacement somatic mutations occurred. After reconstituting the germline Ab from which D1.3 originated, we assessed the energetic and kinetic importance of each of the somatic mutations, individually or combined, using the BIAcore apparatus. We found that the mutations induced an overall 60-fold improvement of affinity, principally due to a decrease in the kinetic rate of dissociation. We showed that their effects were additive and context independent; therefore, in the case of D1.3, the order in which somatic mutations were introduced and selected is unimportant. Interestingly, most of the affinity improvement was due to a single somatic mutation (Asn50-->Tyr in VL), involving a residue that belongs to the functional interface between Ab D1.3 and lysozyme. This replacement could either establish new Van der Waals contacts between the Ab and the Ag or help stabilize the conformation of a closely situated crucial residue of the Ab paratope. The four other mutations played only a marginal part in affinity maturation; potential reasons for which these mutations were nevertheless selected are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973487

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation.

Authors:  Claire L Adams; Megan K L Macleod; E James Milner-White; Robert Aitken; Paul Garside; David I Stott
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  Structural mechanism for affinity maturation of an anti-lysozyme antibody.

Authors:  Ana Cauerhff; Fernando A Goldbaum; Bradford C Braden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

3.  Antibody recognition of a unique tumor-specific glycopeptide antigen.

Authors:  Cory L Brooks; Andrea Schietinger; Svetlana N Borisova; Peter Kufer; Mark Okon; Tomoko Hirama; C Roger Mackenzie; Lai-Xi Wang; Hans Schreiber; Stephen V Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

4.  Exploring peptide mimics for the production of antibodies against discontinuous protein epitopes.

Authors:  Melita B Irving; Lisa Craig; Alfredo Menendez; Beechanahalli P Gangadhar; Marinieve Montero; Nienke E van Houten; Jamie K Scott
Journal:  Mol Immunol       Date:  2009-12-23       Impact factor: 4.407

5.  Hybridization-based antibody cDNA recovery for the production of recombinant antibodies identified by repertoire sequencing.

Authors:  Javier Valdés-Alemán; Juan Téllez-Sosa; Marbella Ovilla-Muñoz; Elizabeth Godoy-Lozano; Daniel Velázquez-Ramírez; Humberto Valdovinos-Torres; Rosa E Gómez-Barreto; Jesús Martinez-Barnetche
Journal:  MAbs       Date:  2013-12-11       Impact factor: 5.857

6.  Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.

Authors:  John T Bates; Christopher J Keefer; Thomas J Utley; Bruno E Correia; William R Schief; James E Crowe
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

7.  Fluorescent labeling of antibody fragments using split GFP.

Authors:  Fortunato Ferrara; Pawel Listwan; Geoffrey S Waldo; Andrew R M Bradbury
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

8.  The structural basis of repertoire shift in an immune response to phosphocholine.

Authors:  M Brown; M A Schumacher; G D Wiens; R G Brennan; M B Rittenberg
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

9.  Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model.

Authors:  Guang Wu; Dongbum Kim; Byoung Kwon Park; Sangkyu Park; Ji-Hee Ha; Te Ha Kim; Avishekh Gautam; Jung Nam Kim; Su In Lee; Han-Bum Park; Yong-Sung Kim; Hyung-Joo Kwon; Younghee Lee
Journal:  Oncotarget       Date:  2016-11-29

10.  Deriving a germinal center lymphocyte migration model from two-photon data.

Authors:  Marc Thilo Figge; Alexandre Garin; Matthias Gunzer; Marie Kosco-Vilbois; Kai-Michael Toellner; Michael Meyer-Hermann
Journal:  J Exp Med       Date:  2008-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.